Announcements Trials
Browse Landscape

Status

Active not recruiting 21Recruiting 17Completed 4Terminated 3Not yet recruiting 3Withdrawn 2Suspended 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 8Lymphoid 5Genitourinary 5Gastrointestinal 4Sarcoma 3Myeloid 3CNS 3Breast 3Tumor-Agnostic 2Dermatologic 2Thoracic 1Plasma cell 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Classical hematology 1

Conditions

Prostatic Neoplasms 1Multiple Myeloma 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

daratumumab 2Dexamethasone 2vactosertib 1selinexor 1pomalidomide 1mirdametinib 1fludarabine phosphate 1carfilzomib 1aldesleukin 1Specimen Handling 1Sirolimus 1Melphalan 1Lenalidomide 1Interleukin-2 1IL32 protein, human 1Cyclophosphamide 1Calcium Dobesilate 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Specimen Handling × Plasma cell × Clear all
NCT04955808 2026-05-13

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

National Cancer Institute (NCI)

Suspended
2,400 enrolled
BreastGastrointestinalGenitourinaryPlasma cell

Breast Neoplasms, Carcinoma, Renal Cell, Colonic Neoplasms, Carcinoma, Hepatocellular, Multiple Myeloma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡